Intelligence · Clinical Development
Pipeline search results
Programs matching “empagliflozin” across our ClinicalTrials.gov index — phase, modality, sponsor, and trial IDs.
Quick answer
Showing 12 pipeline programs matching "empagliflozin" from NovaPharmaNews Clinical Development Intelligence — phase, modality, sponsor, and ClinicalTrials.gov trial IDs.
Refine search
Search results
-
Empagliflozin
Boehringer Ingelheim
Heart Failure
1 trial -
Empagliflozin
Boehringer Ingelheim
Chronic Kidney Disease
1 trial -
Empagliflozin
Boehringer Ingelheim
Myocardial Infarction
1 trial -
Empagliflozin 10 MG
COLLEGIUM PHARMACEUTICAL, INC
Acute Decompensated Heart Failure
1 trial -
Empagliflozin 10 MG
Hospital Authority, Hong Kong
Diabetic Nephropathies
1 trial -
Empagliflozin 10 mg
United Therapeutics Europe Ltd
Acute Myocardial Infarction
1 trial -
Empagliflozin 20 mg
COLLEGIUM PHARMACEUTICAL, INC
Metabolic Syndrome
1 trial -
Bioequivalence Study of Empagliflozin
Zaklady FarmaFarmaceutyczne Polpharma S.Aceutyczne Polpharma S.A.
Not applicable (submitted trial is a BE study in healthy participants)
1 trial -
Empagliflozin 10 MG Oral Tablet [Jardiance]
BRIGHT MINDS BIOSCIENCES INC.
Diabetes Mellitus
1 trial -
Empagliflozin 10 MG
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Pre-Heart Failure
1 trial -
SGLT2 inhibitor (Empagliflozin 25 MG)
Hospital Authority, Hong Kong
Type2 Diabetes
1 trial -
Empagliflozin
MEDA Pharma GmbH & Co. KG
Non Alcoholic Fatty Liver Disease
1 trial
Frequently asked questions
What is the Clinical Development Intelligence Platform?
It is NovaPharmaNews pipeline intelligence hub covering 20,548 clinical development programs — not just a directory. It includes phase distribution dashboards, therapeutic area overviews, NDA/BLA watchlists, upcoming readouts, company pipeline rankings, competitive landscape maps, and personalized watchlists.
How does this compare to Evaluate Pharma or Citeline?
Like Evaluate Pharma and Citeline Trialtrove, we index ClinicalTrials.gov programs by sponsor, phase, and indication. Our platform adds cross-links to NovaPharmaNews company profiles, drug INN pages, patents, and congress readout calendars — improving crawl depth and reducing orphan program pages.
Where does pipeline data come from?
Program records derive from ClinicalTrials.gov and link to sponsor company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment decisions. See our data sources page for attribution.
Can I follow a company or program for updates?
Yes — use the watchlist forms on this page to follow sponsors, individual programs, disease clusters, or therapeutic areas. Alerts use the same subscription infrastructure as our events intelligence hub.